Terragen’s Growth Hinges on Delivery of Major GLP Order Amid Market Uncertainties
Terragen Holdings has secured a major purchase order from Mort & Co Fertilisers for its Great Land Plus® bio-stimulant, projecting a significant sales boost in 2026. This deal underscores growing demand for sustainable agricultural solutions.
- Mort & Co Fertilisers orders 70,000 litres of Great Land Plus®
- Successful trials accelerated manure aging in composting
- Projected 57% increase in GLP sales for calendar year 2026
- Estimated GLP revenue of approximately AUD 700,000 in 2026
- Terragen’s bio-stimulant supports sustainability and productivity goals
A Breakthrough in Sustainable Agriculture
Terragen Holdings Limited, an Australian leader in biological agricultural products, has announced a significant commercial milestone. Following successful product trials, Mort & Co Fertilisers has placed a purchase order for 70,000 litres of Terragen’s flagship bio-stimulant, Great Land Plus® (GLP). This order, scheduled for delivery throughout 2026, marks a pivotal step in Terragen’s growth trajectory and highlights the increasing market appetite for sustainable farming inputs.
From Trials to Tangible Results
The collaboration between Terragen and Mort & Co Fertilisers focused on enhancing the aging process of manure, a critical component in Mort & Co’s organic composting program. The trials demonstrated that GLP effectively accelerates manure aging, improving compost quality and aligning with Mort & Co’s sustainability and productivity objectives. This validation from a key industry player not only confirms GLP’s efficacy but also strengthens Terragen’s position in the competitive bio-stimulant market.
Financial Upside and Market Potential
Terragen forecasts a 57% increase in GLP sales for the calendar year 2026, driven largely by this purchase order and ongoing client demand. The company estimates that GLP will generate approximately AUD 700,000 in revenue next year. While these projections are based on current commitments and internal forecasts, they signal a promising commercial outlook for Terragen’s bio-stimulant portfolio. The company remains cautious, noting that actual results may vary due to market conditions and other external factors.
Strategic Fit and Environmental Impact
Great Land Plus® is designed to reduce reliance on chemical fertilisers by boosting soil health and crop yields through natural biological processes. Terragen’s broader mission is to decarbonise agriculture by offering products that improve both plant and animal health while delivering environmental benefits. The partnership with Mort & Co Fertilisers, a pioneer in organic, carbon-based fertiliser production, exemplifies this strategy and could pave the way for further collaborations in sustainable agriculture.
Looking Ahead
As Terragen prepares to fulfill this substantial order, the market will be watching closely to see how the company scales production and manages delivery schedules. The success of GLP with Mort & Co Fertilisers could open doors to additional contracts and broader adoption across Australia and New Zealand. For investors, this development offers a tangible sign of commercial traction in a sector increasingly focused on environmental stewardship and innovation.
Bottom Line?
Terragen’s GLP order from Mort & Co Fertilisers signals a promising growth phase, but execution and market dynamics will be key to sustaining momentum.
Questions in the middle?
- Can Terragen secure additional large-scale contracts beyond Mort & Co Fertilisers?
- How will Terragen manage production and delivery logistics for the 70,000-litre order?
- What competitive pressures exist in the bio-stimulant market that could impact GLP’s growth?
